Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-09

Clinical Trial Update: Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update examines low-dose aspirin therapy in patients with ischemic stroke and cerebral microbleeds.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Xijing Hospital | Conditions: Ischemic Stroke | Phase 4 | Status: UNKNOWN